| Lindsey Marie Barnett, FNP-C | |
|
1241 E Dyer Rd Ste 145, Santa Ana, CA 92705-5694 | |
| (949) 449-1112 | |
| (714) 368-0843 |
| Full Name | Lindsey Marie Barnett |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1241 E Dyer Rd Ste 145, Santa Ana, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053835637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | AP60769404 (Washington) | Secondary |
| 363L00000X | Nurse Practitioner | AP60769404 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ideal Option Pllc | 6709013105 | 120 |
| Ideal Option Pllc | 6709013105 | 120 |
| Ideal Option Pllc | 6709013105 | 120 |
| Ideal Option Pllc | 6709013105 | 120 |
News Archive
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.
Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
› Verified 2 days ago
| Entity Name | Ideal Option Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457788275 PECOS PAC ID: 6709013105 Enrollment ID: O20131210001184 |
News Archive
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.
Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
› Verified 2 days ago
| Entity Name | Ideal Telemedicine Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346754868 PECOS PAC ID: 2860726221 Enrollment ID: O20190716002000 |
News Archive
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.
Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsey Marie Barnett, FNP-C 841 Nw 19th Ave, Camas, WA 98607-9316 Ph: (541) 905-0120 | Lindsey Marie Barnett, FNP-C 1241 E Dyer Rd Ste 145, Santa Ana, CA 92705-5694 Ph: (949) 449-1112 |
News Archive
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.
Among the most serious consequences of the opioid epidemic is the spread of hepatitis C among injecting drug users.
› Verified 2 days ago
Mr. Gerardo M De Jesus, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 550 N Flower St, Santa Ana, CA 92703 Phone: 714-647-4170 | |
Miss Sonia Sedano, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 N Main St, Santa Ana, CA 92701 Phone: 888-499-9303 | |
Melissa A Medellin, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1002 N Fairview St, Santa Ana, CA 92703 Phone: 714-835-8501 | |
Elizabeth Branson, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2010 E 1st St # 100, Santa Ana, CA 92705 Phone: 909-800-3532 | |
Mr. Ramoncito Llorin Cimarra, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2001 E 4th St Ste 200, Santa Ana, CA 92705 Phone: 562-735-9541 | |
Kimberly A Umansky, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1751 E Garry Ave, Santa Ana, CA 92705 Phone: 877-896-7350 | |
Yingxuan Law, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Park Court Pl Bldg H, Santa Ana, CA 92701 Phone: 206-817-2984 |